Cargando…

Intermediate-High Risk Pulmonary Embolism

Limited information exists about the prevalence, management, and outcomes of intermediate-high risk patients with acute pulmonary embolism (PE). In a prospective cohort study, we evaluated consecutive patients with intermediate-high risk PE at a large, tertiary, academic medical center between Janua...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirambeaux, Rosa, León, Francisco, Bikdeli, Behnood, Morillo, Raquel, Barrios, Deisy, Mercedes, Edwin, Moores, Lisa, Tapson, Victor, Yusen, Roger D., Jiménez, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2019
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892655/ https://www.ncbi.nlm.nih.gov/pubmed/31815247 http://dx.doi.org/10.1055/s-0039-3401003

Ejemplares similares

Revised Paradigm for Acute Pulmonary Embolism Prognostication and Treatment
por: Jiménez, David, et al.
Publicado: (2023)

Implications of Abnormal Troponin Levels With Normal Right Ventricular Function in Normotensive Patients With Acute Pulmonary Embolism
por: Mirambeaux, Rosa, et al.
Publicado: (2020)

Sex differences in the characteristics and short-term prognosis of patients presenting with acute symptomatic pulmonary embolism
por: Barrios, Deisy, et al.
Publicado: (2017)

Adjusted D-dimer cutoff levels to rule out pulmonary embolism in patients hospitalized for COPD exacerbation: results from the SLICE trial
por: Rodríguez, Carmen, et al.
Publicado: (2022)

Hospital volume and outcomes for acute pulmonary embolism: multinational population based cohort study
por: Jiménez, David, et al.
Publicado: (2019)

Advances in the Diagnosis and Treatment of Acute Pulmonary Embolism
por: Tapson, Victor F.
Publicado: (2012)

Advances in the diagnosis of acute pulmonary embolism
por: Ishaaya, Ella, et al.
Publicado: (2020)

Effect of Prognostic Guided Management of Patients With Acute Pulmonary Embolism According to the European Society of Cardiology Risk Stratification Model
por: Jiménez, David, et al.
Publicado: (2022)

Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
por: Bikdeli, Behnood
Publicado: (2020)

To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
por: Bikdeli, Behnood
Publicado: (2022)

Early Use of Echocardiography in Patients With Acute Pulmonary Embolism: Findings From the RIETE Registry
por: Bikdeli, Behnood, et al.
Publicado: (2018)

Annual Mortality Related to Pulmonary Embolism in the U.S. Before and During the COVID-19 Pandemic
por: Farmakis, Ioannis T., et al.
Publicado: (2022)

Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism: A Persian-speaking cohort
por: Mehdizadeh, Kasra, et al.
Publicado: (2023)

Closer to FREEDOM From Uncertainty
por: Vaduganathan, Muthiah, et al.
Publicado: (2023)

Omega-3 Supplements and Cardiovascular Diseases
por: Mohebi-Nejad, Azin, et al.
Publicado: (2014)

Intermediate pulmonary embolism: Diagnosis and management
por: Davidson, Bruce L
Publicado: (2019)

Association Between Preexisting Versus Newly Identified Atrial Fibrillation and Outcomes of Patients With Acute Pulmonary Embolism
por: Bikdeli, Behnood, et al.
Publicado: (2021)

Clinical and echocardiographic predictors of mortality in acute pulmonary embolism
por: Dahhan, Talal, et al.
Publicado: (2016)

Pulmonary embolism response teams in the challenging era of venous thromboembolism associated with COVID-19
por: Porres-Aguilar, Mateo, et al.
Publicado: (2020)

Comparison of 4 Acute Pulmonary Embolism Mortality Risk Scores in Patients Evaluated by Pulmonary Embolism Response Teams
por: Barnes, Geoffrey D., et al.
Publicado: (2020)

Cardiac rupture after ST-elevation myocardial infarction (STEMI): a ‘Stitch’ in time?
por: Nagraj, Sanjana, et al.
Publicado: (2022)

Real-Time Dissemination of Aggregate Data on Presentation and Outcomes of Patients With Venous Thromboembolism: The RIETE Infographics Project
por: Tafur, Alfonso, et al.
Publicado: (2020)

Intermediate-risk pulmonary embolism: echocardiography predictors of clinical deterioration
por: Weekes, Anthony J., et al.
Publicado: (2022)

Thromboprophylaxis strategies to improve the prognosis of COVID-19
por: Bertoletti, Laurent, et al.
Publicado: (2021)

Pulmonary artery catheter-directed thrombolysis for intermediate high risk acute pulmonary embolism
por: Singh, Abhijeet, et al.
Publicado: (2017)

Cardiovascular Ultrasound in the Diagnosis and Management of Acute Intermediate-Risk Pulmonary Embolism
por: Fabijanic, Damir, et al.
Publicado: (2012)

Recovery of right ventricular function after intermediate-risk pulmonary embolism: results from the multicentre Pulmonary Embolism International Trial (PEITHO)-2
por: Mavromanoli, Anna C., et al.
Publicado: (2022)

Higher Adherence to Treatment With Low-Molecular-Weight-Heparin Nadroparin Than Enoxaparin Because of Side Effects in Cancer-Associated Venous Thromboembolism
por: van der Wall, Sake J., et al.
Publicado: (2018)

Variable Resistance to Plasminogen Activator Initiated Fibrinolysis for Intermediate-Risk Pulmonary Embolism
por: Stubblefield, William B., et al.
Publicado: (2016)

Efficacy and safety of hydro-mechanical defragmentation in intermediate- and high-risk pulmonary embolism
por: Hassan, Ayman K. M., et al.
Publicado: (2021)

Changing biventricular mechanics during thrombectomy for intermediate high-risk pulmonary embolism
por: van den Enden, Antoon J M, et al.
Publicado: (2022)

Reduced-Dose Intravenous Thrombolysis for Acute Intermediate–High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial
por: Sanchez, Olivier, et al.
Publicado: (2021)

One-Year Echocardiographic, Functional, and Quality of Life Outcomes After Ultrasound-Facilitated Catheter-Based Fibrinolysis for Pulmonary Embolism
por: Piazza, Gregory, et al.
Publicado: (2020)

Role of Pulmonary Embolism Response Team in patients with intermediate- and high-risk pulmonary embolism: a concise review and preliminary experience from China
por: LIANG, Ying, et al.
Publicado: (2020)

Pulmonary vasodilation by sildenafil in acute intermediate-high risk pulmonary embolism: a randomized explorative trial
por: Andersen, Asger, et al.
Publicado: (2021)

Predictors of residual pulmonary vascular obstruction after anticoagulation monotherapy in patients with intermediate-risk pulmonary embolism
por: Chang, Youjin, et al.
Publicado: (2021)

Vaccine-induced immune thrombotic thrombocytopenia after the BNT162b2 mRNA Covid-19 vaccine: A case study
por: Rodríguez, Carmen, et al.
Publicado: (2021)

A systematic review for the role of systemic thrombolysis in intermediate-risk (submassive) pulmonary embolism
por: Seif, Mohamed Ahmed
Publicado: (2020)

Safety of early orthopedic surgery in patients with intermediate/low- or low-risk pulmonary embolism
por: Kim, Ho Cheol, et al.
Publicado: (2020)

In-hospital and short-term predictors of mortality in patients with intermediate-high risk pulmonary embolism
por: Gök, Gulay, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8notptbkpiauk8sdmsk0ekvtoj